United Laboratories International Holdings Ltd (3933)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 21 Oct 2026
Key indicators
| Last close | HKD 7.220 |
|---|---|
| 52-week range | 7.155 – 13.377 |
| Return, 1 month / 3 months | −8.8% / −21.7% |
| Return, 1 year / 3 years | −45.8% / +20.8% |
| Trend | Below its 200-day average |
| RSI (14) | 34 |
| Volatility (1 year) | 38.7% |
| Worst drawdown (1 year) | -45.6% |
| Average daily value traded | 51.26M HKD |
| Dividend yield | 4.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
United Laboratories International Holdings is a pharmaceutical company that develops, manufactures and sells medicines, with a focus on antibiotics and related products. It produces active pharmaceutical ingredients as well as finished dosage forms such as tablets, capsules and injectables. The company serves hospitals, clinics and distributors, mainly in the Chinese market, and also supplies customers in other countries. It is based in Hong Kong and operates manufacturing facilities in mainland China.
The shares are listed on the Hong Kong Stock Exchange in Hong Kong under the code 3933, and the price on this page is in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
United Laboratories International Holdings Ltd (3933) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 7.220 on 21 October 2026.
Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 1,403 of 2,611 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 45.8% and over the last three months it fell 21.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 32 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -24.5% | ||
| From 52-week high | -45.6% | ||
| Momentum | 25 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -21.7% | ||
| 6-month return | -25.8% | ||
| 12-month return, skipping the last month | -40.5% | ||
| Stability (higher is calmer) | 64 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 38.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -45.6% | ||
| Liquidity | 87 · Strong | Trades actively. | |
| Average daily value traded | 51.26M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | 50 · Weak | Dividend is small or irregular. | |
| Dividend yield | 4.1% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | −2.8% |
|---|---|
| 1 month | −8.8% |
| 3 months | −21.7% |
| 6 months | −25.8% |
| 1 year | −45.8% |
| 3 years | +20.8% |
| 5 years | – |
Signals
| 50-day / 200-day average | 8.108 / 9.564 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.255 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 Jul 2026 | HKD 0.2990 |
| 25 Sep 2025 | HKD 0.1751 |
| 8 Jul 2025 | HKD 0.1314 |
| 19 Sep 2024 | HKD 0.1763 |
| 2 Jul 2024 | HKD 0.1317 |
| 17 Jun 2024 | HKD 0.2800 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.